• 首页
  • 期刊简介
  • 编委会
    第六届编委会
  • 投稿须知
    文章要求
    投稿指南
    发表学术论文“五不准”
  • 本刊稿约
  • 期刊公告
  • 联系我们
引用本文:
【打印本页】   【下载PDF全文】     【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 3958次   下载 0次 本文二维码信息
码上扫一扫!
脑动脉粥样硬化患者血脂及修饰化脂蛋白水平的研究
罗薇;郭英;周莉莎;丁霏;李小玲;贺勇;聂鑫;宋昊岚;李贵星;
四川大学华西医院实验医学科
摘要:
目的分析脑动脉粥样硬化患者血脂、修饰化脂蛋白及脂蛋白相关磷脂酶A2水平,研究修饰化脂蛋白及脂蛋白相关磷脂酶A2与脑动脉粥样硬化发生的关系。方法以2016年5月至2016年9月因缺血性脑卒中就诊于华西医院神经内科确诊为脑动脉粥样硬化患者共183例为病例组,以同期华西医院体检中心健康体检者180例为对照组,采用酶联免疫吸附法测定修饰化脂蛋白水平,比较病例组与对照组修饰化脂蛋白水平差异。结果脑动脉粥样硬化组血糖水平为6.14(5.21,7.67)(mmol/L)高于健康对照组的4.84(4.68,5.21)(P<0.05),甘油三酯在两组间无差异(P>0.05),病例组胆固醇、低密度脂蛋白-胆固醇、高密度脂蛋白-胆固醇水平均低于对照组,结果为3.57(3.07,4.17)vs 5.24(4.86,5.75)(mmol/L);1.83(1.46,2.30)vs 2.97(2.58,3.23)(mmol/L);1.11(0.84,1.36)vs 1.43(1.17,1.76)(mmol/L)(P<0.05)。病例组氧化高密度脂蛋白、氧化低密度脂蛋白、糖化高密度脂蛋白、糖化低密度脂蛋白、脂蛋白相关磷脂酶A2水平均对照组,结果为75.48(68.56,78.55)vs 40.60(32.76,47.92)(ng/mL);15.81(11.29,19.07)vs 12.22(11.46,13.38)(μg/mL);4.79(3.77,6.48)vs 2.55(1.86,4.33)(ng/mL);31.20(24.39,40.56)vs 24.69(19.16,33.19)(ng/mL);7.73(5.81,10.35)vs 4.20(3.62,5.42)(ng/mL),差异有统计学意义(P<0.05)。结论脂质不是脑动脉粥样硬化形成的主要危险因素,高血糖和修饰化脂蛋白及脂蛋白相关磷脂酶A2水平升高是脑动脉粥样硬化发生发展的重要因素。
关键词:  动脉粥样硬化  缺血性脑卒中  修饰化脂蛋白  脂质相关磷脂酶A2
DOI:
分类号:R743.1; R341.35; R345
基金项目:
Study of Blood Lipids and Modified Lipoprotein in Patients with Cerebral Atherosclerosis
Luo Wei;Guo Ying;Zhou Lisha
West China Hospital of Sichuan University
Abstract:
Objective To analyze the levels of blood lipids,modified lipoproteins and lipoprotein-associated phospholipase A2 in patients with cerebral atherosclerosis and investigate the relationship between modified lipoproteins and lipoprotein-associated phospholipase A2 and cerebral atherosclerosis.Methods 183 cases diagnosed as cerebral atherosclerosis admitted to West China Hospital for ischemic stroke from May 2016 to September 2016 were selected as the case group and 180 cases of healthy subjects in Physical Examination Center of West China Hospital during the same period were selected as the control group.the level of modified lipoprotein was measured by enzyme-linked immunosorbent assay( ELISA),and the difference of modified lipoprotein between the case group and the control group was compared.Results Blood glucose level in cerebral atherosclerosis group was 6. 14( 5. 21,7. 67)( mmol/L),higher than that in healthy control group 4. 84( 4. 68,5. 21) with statistical significance( P <0. 05).There was no difference in triglyceride between the two groups( P > 0. 05). The levels of cholesterol,low density lipoprotein-cholesterol and high-density lipoprotein-cholesterol were lower in the case group than those in the control group with statistical significance( P<0. 05),and the results were 3. 57( 3. 07,4. 17) vs 5. 24( 4. 86,5. 75)( mmol/L); 1. 83( 1. 46,2. 30) vs 2. 97( 2. 58,3. 23)( mmol/L); 1. 11( 0. 84,1. 36) vs 1. 43( 1. 17,1. 76)( mmol/L)( P<0. 05).The levels of oxidized high density lipoprotein,oxidized low density lipoprotein,glycated high density lipoprotein,glycosylated low density lipoprotein and lipoprotein associated phospholipase A2 in the case group were significantly higher than those in the control group( P < 0. 05),and the results were 75. 48( 68. 56,78. 55) vs 40. 60( 32. 76,47. 92)( ng/mL); 15. 81( 11. 29,19. 07) vs 12. 22( 11. 46,13. 38)( μg/mL); 4. 79( 3. 77,6. 48) vs 2. 55( 1. 86,4. 33)( ng/mL); 31. 20( 24. 39,40. 56) vs 24. 69( 19. 16,33. 19)( ng/mL); 7. 73( 5. 81,10. 35) vs 4. 20( 3. 62,5. 42)( ng/mL) respectively. Conclusion Lipid is not the main risk factor of cerebral atherosclerosis,but the high level of phospholipase A2,hyperglycemia,modified lipoprotein are important factors in the development of cerebral atherosclerosis
Key words:  atherosclerosis  ischemicstroke  modifiedlipoproteins  lipid-associatedphospholipaseA2
您是本站第  91505038  位访问者!蜀ICP备11024768号
版权所有:(C)四川省医疗卫生服务指导中心 2010 CopyRight http://scmj.scyx.org.cn/ all right reserved.
地址:成都市玉林南街2号附3号   电话:028-86136765 邮编:610041
技术支持:北京勤云科技发展有限公司